Trial Profile
A retrospective, case-controlled study evaluating the effects of previous radiotherapy on outcomes of nivolumab in patients with advanced NSCLC non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2018
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2018 New trial record
- 19 Sep 2018 Results presented at the 28th Annual Congress of the European Respiratory Society